Skip to main content

Refine your results

Filters

Displaying 1101 - 1120 of 1541

Cases and Proceedings

DaVita, Inc.

The consent order resolves the competitive issues raised by DaVita’s proposed $3.1 billion purchase of rival outpatient dialysis clinic operator Gambro Healthcare Inc. from Gambro AB. Pursuant to the order, DaVita sold 69 dialysis clinics and end two management services contracts in 35 markets across the United States within 10 days of consummating its purchase of Gambro. The Commission has approved Renal Advantage Inc. as the buyer of most of the clinics to be divested, and entered into an order to maintain assets with DaVita.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0510051
Docket Number
C-4152
Cases and Proceedings

Allergan, Inc., and Inamed Corporation, In the Matter of

The consent order requires that Allergan and Inamed divest the rights to develop and distribute Reloxin, a potential Botox rival, to settle charges that Allergan’s $3.2 billion purchase of Inamed would reduce competition and force consumers to pay higher prices for botulinum toxin type A products. Under the terms of the FTC settlement, the companies will return the development and distribution rights to Reloxin to Ipsen Ltd., its U.K.- based manufacturer.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
061 0031
Docket Number
C-4156
Cases and Proceedings

Health Care Alliance of Laredo, L.C., In the Matter of

A physicians’ independent practice association in Texas agreed to settle charges that it engaged in unlawful collective bargaining to set fees its members would accept from health insurance plans and advised its members against dealing individually with plans. The Commission charged that both practices resulted in higher medical costs for consumers. The consent order settling the FTC’s charges will prohibit the IPA from engaging in such anticompetitive conduct in the future.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410097
Cases and Proceedings

Teva Pharmaceutical Industries Ltd. and IVAX Corporation, In the Matter of

The consent order allowed Teva to acquire IVAX Corporation, provided the companies sell the rights and assets needed to manufacture and market 15 generic pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and amoxicillin clavulanate potassium that are widely used in the United States.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
051 0214
Docket Number
C-4155
Press Release

Announced Action for January 27, 2006

Date
Commission authorization of the filing of staff comment: The Commission has authorized the staffs of the Office of Policy Planning, Bureau of Consumer Protection, and Bureau of Economics to file a...
Press Release

Announced Action for November 18, 2005

Date
Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning DaVita, Inc. and Gambro AB...

Displaying 1101 - 1120 of 1541

Return to top